These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23474763)

  • 1. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.
    Xie X; Piao L; Bullock BN; Smith A; Su T; Zhang M; Teknos TN; Arora PS; Pan Q
    Oncogene; 2014 Feb; 33(8):1037-46. PubMed ID: 23474763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
    Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X
    Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.
    Masand RP; El-Mofty SK; Ma XJ; Luo Y; Flanagan JJ; Lewis JS
    Head Neck Pathol; 2011 Jun; 5(2):108-16. PubMed ID: 21305368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.
    Qian G; Wang D; Magliocca KR; Hu Z; Nannapaneni S; Kim S; Chen Z; Sun SY; Shin DM; Saba NF; Chen ZG
    Eur J Cancer; 2016 Sep; 65():21-32. PubMed ID: 27451021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.
    Caicedo-Granados E; Lin R; Fujisawa C; Yueh B; Sangwan V; Saluja A
    Oral Oncol; 2014 Dec; 50(12):1149-56. PubMed ID: 25311433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
    Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
    Nantajit D; Presta L; Sauter T; Tavassoli M
    Cell Death Dis; 2022 Nov; 13(11):921. PubMed ID: 36333293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
    Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
    Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.
    Celegato M; Messa L; Goracci L; Mercorelli B; Bertagnin C; Spyrakis F; Suarez I; Cousido-Siah A; Travé G; Banks L; Cruciani G; Palù G; Loregian A
    Cancer Lett; 2020 Feb; 470():115-125. PubMed ID: 31693922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
    Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
    J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
    Hebner C; Beglin M; Laimins LA
    J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells.
    Yuan CH; Filippova M; Krstenansky JL; Duerksen-Hughes PJ
    Cell Death Dis; 2016 Jan; 7(1):2060. PubMed ID: 26794656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can liberating p53 from E6 free patients from HPV-related head and neck tumors?
    Jung AC
    Cell Cycle; 2013 Mar; 12(6):868. PubMed ID: 23442795
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
    van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH
    Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.